Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
Crossref DOI link: https://doi.org/10.1007/s00280-017-3457-8
Published Online: 2017-11-20
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Markus, Richard
Chow, Vincent
Pan, Zhiying
Hanes, Vladimir
License valid from 2017-11-20